glp 1 guidelines for weight loss GLP-1-directed NMDA receptor antagonism obesity treatment Updated guidance for patients using

289 The rise in cAMP activates PKA, a versatile protein kinase that phosphorylates various target proteins

North America dominated the GLP-1 receptor agonist market with a market share of 61.23% in 2025

These agents act through multiple mechanisms, including direct cardioprotection, vasodilation, natriuresis, weight reduction, lipid profile improvement, anti-inflammatory effects, renal protection, reduction in plaque formation, and neurohormonal regulation

According to the drug label, Mounjaro is most likely to reduce birth control efficacy after the first dose, with this potential side effect diminishing over time

Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials